Cholesterol Could Be Link Between Menopause and Heart Disease
By Dennis Thompson HealthDay Reporter
TUESDAY, Aug. 27, 2024 -- During menopause, a woman’s blood cholesterol changes in a way that could harm her heart health, a new study warns.
An increase in “bad” LDL cholesterol and a decrease in “good” HDL cholesterol occurs during menopause, according to research being presented Sept. 2 at the European Society of Cardiology’s annual meeting in London.
“Taken together, these changes suggest that menopause is associated with a transition to a higher-risk lipoprotein [cholesterol] profile that could be more likely to cause cardiovascular disease, such as coronary artery disease,” said researcher Dr. Stephanie Moreno, a resident with the University of Texas Southwestern Medical Center in Dallas.
Heart disease is the biggest killer of women, causing 40% of all deaths in females, researchers noted.
Women tend to develop heart disease about 10 years later than men, with their risk rising dramatically after menopause.
But until now, it’s been unclear why a woman’s risk of heart disease accelerates following menopause.
For this study, researchers analyzed blood cholesterol levels in 1,246 women and 1,346 men participating in a long-term heart health study.
Of the women, 35% were premenopausal, 24% were menopausal and 41% were postmenopausal.
Over an average follow-up time of seven years, all three groups of women experienced an increase in “bad” LDL cholesterol.
However, the greatest percent change in LDL cholesterol occurred between menopause and postmenopause, with levels rising 8.3%, researchers found. Further, postmenopausal women also experienced a 4.8% decline in their levels of “good” HDL cholesterol.
Compared to men, the picture was not pretty: Menopausal women had a 213% increase in “bad” LDL cholesterol, results showed.
“We found that menopause is associated with adverse changes in lipoprotein profiles, with the most pronounced changes found to be in increases in ‘bad’ LDL-particles,” Moreno said in a meeting news release.
“When looked at together, these changes could help explain the increase of cardiovascular disease in postmenopausal women and help determine if earlier interventions are warranted,” Moreno added.
More research is needed to see if these changes in cholesterol directly translate to greater heart health risk, Moreno said.
Because these findings were presented at a medical meeting, they should be considered preliminary until published in a peer-reviewed journal.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-28 10:28
Read more
- Total Hip Replacement Revision Rates Vary With Type of Material Used
- What You Need to Know About FluMist, the Nasal Flu Vaccine
- AAO: One Year of Valacyclovir Beneficial for Herpes Zoster Ophthalmicus
- Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
- Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
- Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions